Data up to Jan 2025
Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study.
1991 • 159 citations
Estrogen and progesterone receptors in uterine sarcomas.
1986 • 80 citations